Pablo Legorreta (#970)
- $ 4 B
- Investments
- United States
- M
- 62 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Pablo Legorreta is the founder of Royalty Pharma, the world's biggest acquirer of pharmaceutical royalty streams. Royalty Pharma, which conducted an IPO in 2020, has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica, and Xtandi. A former investment banker at Lazard Fr'res, Legoretta started Royalty Pharma in New York as a private equity vehicle in 1996. In May 2025, Royalty Pharma acquired its external investment manager RP Management in a $1.1 billion deal. Legorreta owned 100% of RPM until 2024, when he gave just under half his stake to employees
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Pablo Legorreta’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Pablo Legorreta’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $4.4B
(May 4, 2026)
© Iconic Billionaires